Understanding cancer data reporting timelines

The National Cancer Registry Ireland (NCRI) is committed to providing accurate, reliable and meaningful information on cancer in Ireland. Because of how cancer data are collected, validated and analysed, there is a necessary time lag of around two years between when a cancer is diagnosed and when final national statistics can be published.

This time lag is not a delay in reporting, but a reflection of the careful and rigorous processes required to ensure that the data we publish are complete, accurate, and comparable over time and across countries. These qualities are what make NCRI data a trusted source for cancer policy, service planning, research, and public understanding.

Provisional and finalised cancer incidence reporting

Cancer incidence data can be produced at different stages of completeness. In the period shortly after diagnosis, information received by the NCRI may be incomplete and subject to change as further notifications, clinical details, pathology results, and updates are received. At this stage, data are referred to as provisional.

Provisional incidence figures typically represent an undercount of the true number of cancer cases. This is because not all cases have yet been reported, some records are missing key diagnostic information, and others require clarification or confirmation. Provisional data are therefore not suitable for national reporting, trend analysis, international comparison, or policy evaluation.

Finalised incidence data are produced only after sufficient time has passed to ensure that case ascertainment is as complete as possible and that records have undergone full validation and quality assurance. Once finalised, incidence statistics provide a stable and reliable measure of cancer burden that does not change over time and can be confidently used for planning, research, and monitoring trends.

The NCRI prioritises the publication of finalised rather than provisional incidence data in order to avoid misleading results, artificial trends, or incorrect comparisons that could arise from the use of incomplete data.

Why NCRI data matter for policy and service planning

In the Irish health system, population‑based cancer registry data collected and quality‑assured by the NCRI play a central role in national cancer policy development and long‑term service planning. NCRI data provide comprehensive, population‑wide information on cancer incidence, survival, stage at diagnosis, and trends over time.

These data support the National Cancer Strategy, the work of the National Cancer Control Programme (NCCP), and Department of Health decision‑making. They are used to understand outcomes, evaluate screening and treatment pathways, identify inequalities, benchmark Ireland’s performance internationally, and inform sustainable decisions about workforce, infrastructure, and service configuration.

A defining feature of NCRI data is that they are systematically validated and harmonised across multiple data sources. While this necessarily introduces a time lag before publication, it ensures high standards of completeness, accuracy, and comparability, which are essential for effective policy and planning.

How cancer data are collected

Cancer registration is a complex and continuous process. Before a cancer record is fully registered, NCRI staff follow multiple steps to collect, collate, match, and validate information.

Data are gathered from a wide range of sources, including all hospitals in Ireland, pathology laboratories, death registration, and screening programmes. The timing and methods of reporting vary across hospitals depending on local systems, and the process relies on timely and uninterrupted access to these data sources.

Importantly, information does not arrive at the Registry all at once. Some details are received quickly, while other key information - such as tumour characteristics, stage at diagnosis, treatments received, or updates following further investigations - may only become available months later. Allowing time for all relevant information to be reported, updated, and linked together is essential to build a complete and accurate record for each cancer case.

Recording treatment and follow‑up

Primary cancer treatment is typically recorded over a period of approximately 12 months following diagnosis. This directly affects the timeframe needed to complete data collection, matching, and validation.

Many cancer statistics - including stage at diagnosis, patterns of care, and survival - require follow‑up information that is not available immediately after diagnosis. Allowing time for this follow‑up ensures that analyses are robust and meaningful, and that trends over time reflect real changes rather than incomplete or provisional data.

Why completeness and quality matter more than immediacy

Population‑level cancer risk changes slowly over time. It is driven primarily by long‑term factors such as population ageing, demographic change, cumulative lifetime exposures (for example tobacco, alcohol, obesity, and environmental risks), and broader socioeconomic conditions.

Because these factors evolve gradually over decades rather than year‑to‑year, cancer data that are a few years old still provide a reliable reflection of underlying patterns of cancer burden and service need. Short‑term fluctuations are unlikely to materially alter population risk, meaning recently lagged data remain robust and appropriate for strategic planning and policy evaluation.

By contrast, publishing cancer statistics too early would risk under‑counting cases, missing later updates, or producing misleading trends. Thorough case identification, validation, and follow‑up are essential to ensure that long‑term analyses are reliable and comparable.

Ensuring accuracy and completeness

Once data are received, they undergo extensive quality checks and validation, including:

• removing duplicate records
• resolving conflicting or missing information
• confirming cancer type and date of diagnosis
• ensuring consistency with international coding standards

These steps are essential to maintaining the integrity of cancer statistics. Taking the time to complete these checks ensures that NCRI outputs can be confidently used by clinicians, researchers, policymakers, and the public.

Cancer registry data and “real‑time” data: different purposes

In the Irish health system, different types of data serve different but complementary roles.

“Real‑time” or near‑real‑time data typically refer to operational information from hospital and national systems, such as service activity levels, waiting lists, diagnostics throughput, and bed capacity. These data are primarily used by the HSE and NCCP to support day‑to‑day operational management of cancer services and to respond to immediate pressures.

Cancer registry data, by contrast, are designed to measure population cancer burden, outcomes, and trends over time. While they are less immediate, they provide the validated, population‑wide evidence needed to assess long‑term impact, plan future services, evaluate policy, and make international comparisons. Both forms of data are essential and work best when used together, each for its intended purpose.

International best practice

A reporting lag of around two years is standard among population‑based cancer registries internationally. Following this approach ensures that Irish cancer statistics are comparable with those from other countries and meet international quality standards.

Our commitment

While a delay in reporting is unavoidable, the NCRI works continuously to improve the timeliness, quality, and usefulness of cancer data. We regularly review our processes, invest in data systems, and collaborate closely with data providers to minimise delays while maintaining the highest standards.

By taking the time to get the data right, we ensure that NCRI statistics remain Ireland’s most comprehensive and trusted source of cancer information — supporting cancer services, research, policy development, and public understanding.